284 related articles for article (PubMed ID: 19320477)
1. Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.
Shi J; Kim YS; Zhai S; Liu Z; Chen X; Liu S
Bioconjug Chem; 2009 Apr; 20(4):750-9. PubMed ID: 19320477
[TBL] [Abstract][Full Text] [Related]
2. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S
Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525
[TBL] [Abstract][Full Text] [Related]
3. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928
[TBL] [Abstract][Full Text] [Related]
4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.
Chakraborty S; Shi J; Kim YS; Zhou Y; Jia B; Wang F; Liu S
Bioconjug Chem; 2010 May; 21(5):969-78. PubMed ID: 20387808
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
Liu Z; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability.
Shi J; Zhou Y; Chakraborty S; Kim YS; Jia B; Wang F; Liu S
Theranostics; 2011; 1():322-40. PubMed ID: 21850213
[TBL] [Abstract][Full Text] [Related]
8. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
9. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
10. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
[TBL] [Abstract][Full Text] [Related]
11. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236
[TBL] [Abstract][Full Text] [Related]
12. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
[TBL] [Abstract][Full Text] [Related]
13. Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers.
Shi J; Wang L; Kim YS; Zhai S; Liu Z; Chen X; Liu S
J Med Chem; 2008 Dec; 51(24):7980-90. PubMed ID: 19049428
[TBL] [Abstract][Full Text] [Related]
14. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
15. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
Zhou Y; Kim YS; Lu X; Liu S
Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387
[TBL] [Abstract][Full Text] [Related]
17. Novel
Lucente E; Liu H; Liu Y; Hu X; Lacivita E; Leopoldo M; Cheng Z
Bioconjug Chem; 2018 May; 29(5):1595-1604. PubMed ID: 29587479
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]